1. Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure
   Chun-Yang Xiao et al, 2005, The Journal of Pharmacology and Experimental Therapeutics CrossRef
2. A Newly Synthesized Poly(ADP-Ribose) Polymerase Inhibitor, DR2313 [2-Methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: Pharmacological Profiles, Neuroprotective Effects, and Therapeutic Time Window in Cerebral Ischemia in Rats
   Hidemitsu Nakajima et al, 2005, The Journal of Pharmacology and Experimental Therapeutics CrossRef
3. Targeting Parthanatos in Ischemic Stroke
   Raymond C. Koehler et al, 2021, Frontiers in Neurology CrossRef
4. Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases
   Jie Tong et al, 2022, Frontiers in Medicine CrossRef
5. Neuroprotectants
   Neel S. Singhal et al, 2024, Ischemic Stroke Therapeutics CrossRef